Payment Orchestration Platform Leader IXOPAY Appoints Suzanne Rudnitzki as President & Chief Operating Officer
Rudnitzki joins IXOPAY to accelerate growth and transform the global payments industry
TULSA, OK / ACCESSWIRE / October 25, 2024 / IXOPAY, a leading provider of enterprise-grade payment orchestration, announced the appointment of Suzanne Rudnitzki as President & Chief Operating Officer. The appointment strengthens IXOPAY's ability to lead the global payments industry to a global multiprocessor architecture.
IXOPAY Logo
IXOPAY Logo
Rudnitzki, a former private equity executive and Executive in Residence at IXOPAY, played a key role in IXOPAY's strategic merger with TokenEx earlier this year and in assembling new leaders to seize the growing payment orchestration market opportunity.
Rudnitzki will work with IXOPAY CEO Brady Harris and the broader leadership team, including recently appointed CTO Ronnie Thomson and CCO Kelly Wenzel, to optimize and scale IXOPAY's payment orchestration platform and payment optimization modules for customers worldwide.
"IXOPAY is disrupting the global payments industry by addressing a critical issue - the need for seamless integration across multiple payment service providers," said Rudnitzki. "Merchants are increasingly adopting a multiprocessor strategy with IXOPAY's enterprise-grade payment orchestration platform - boosting both their top and bottom line via increased authorization rates, enhanced security, and improved customer retention. I'm proud to become a permanent part of the team driving this global payments transformation."
"We're thrilled to welcome Suzanne Rudnitzki as President and Chief Operating Officer. With Suzanne's leadership, we will sharpen our operational strategy and position IXOPAY as the global leader in payment orchestration," said Brady Harris, CEO of IXOPAY. "Her experience scaling software companies and driving growth through strategic mergers and acquisitions will be invaluable as IXOPAY leads the payments industry toward a global multiprocessor future."
Rudnitzki is a highly experienced executive in the fintech and SaaS sectors, formerly serving as Chief Operating Officer at Smarsh, a global leader in financial compliance technology. There she led international teams across the U.S., UK, and India, while playing a central role in executing strategic mergers and acquisitions, and driving operational efficiency.
She will join IXOPAY CEO Brady Harris at Money20/20 in Las Vegas from October 27-30, where they will discuss IXOPAY's innovative solutions and future growth plans. Attendees interested in learning more are encouraged to connect with them during the event at Booth #11213.
About IXOPAY
IXOPAY is a leading provider of enterprise-grade payment orchestration, providing a fully integrated platform and flexible payment optimization modules to businesses around the world. With a single API and scalable payments architecture, IXOPAY empowers businesses to simplify, secure and increase the resilience of their payment systems. Learn more at www.ixopay.com.
Contact Information
Mills Forni
Partner, Verdis
mills@verdis.xyz
+1 802-335-2603
Related Images
|
SOURCE: IXOPAY
View the original press release on newswire.com.
IXOPAY
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
SK tes Launches New Circular IT Facility in Shannon, Expanding Ireland’s Role in Global Sustainable Tech Services24.4.2025 09:30:00 CEST | Press release
SHANNON, IE / ACCESS Newswire / April 24, 2025 / SK tes, a global leader in sustainable IT asset disposition (ITAD) and technology lifecycle services, has announced plans to open a new 36,000 square foot purpose-built facility in Shannon, marking a major vote of confidence in Ireland's thriving data and technology sector. The new facility will deliver comprehensive ITAD, data center decommissioning, and technology lifecycle management services to some of Ireland's largest enterprises, including hyperscale data center operators, while supporting national sustainability and circular economy goals. It will also create over 25 skilled jobs in one of the country's fastest-growing tech regions. "Ireland is at the forefront of Europe's digital economy, and our investment in Shannon reinforces our commitment to helping Irish companies manage technology securely, sustainably, and at scale," said Eric Ingebretsen, Chief Commercial Officer at SK tes. "This facility will allow us to meet the uniqu
Sauce Labs Launches Industry-First Enterprise Scale iOS 18 Testing on Sauce Labs Virtual Device Cloud, Boosting Test Speeds up to 40%24.4.2025 08:00:00 CEST | Press release
Leading test automation platform, powering development for over 300,000 active users and having executed more than 8 billion tests, enables developers and QA teams to ensure app quality on Apple's latest OS with unprecedented performance and scale. SAN FRANCISCO, CA / ACCESS Newswire / April 24, 2025 / Sauce Labs Inc., the leading platform for continuous quality, trusted by dev teams around the world to deliver apps users love, today announced the general availability of iOS 18 testing on its Virtual Device Cloud (VDC). Leveraging its new, high-performance Apple Silicon cloud infrastructure, Sauce Labs offers the market's most scalable enterprise-ready solution for automated mobile app and web testing on iOS 17.5, iOS 18, and beyond, enabling teams to execute tests up to 40% faster compared to previous versions. This launch addresses the critical need for timely testing support driven by Apple's transition to its proprietary Apple Silicon architecture and the rapid adoption rate of new
Introducing NUGEN(R) HLD-CD by Arxada: A Game-Changer in Healthcare Disinfection24.4.2025 07:00:00 CEST | Press release
Delivering Effective Germ Control in Five Minutes BASEL, CH / ACCESS Newswire / April 24, 2025 / Arxada, a global leader in specialty chemicals and innovative solutions, announces the launch of NUGEN® HLD-CD, a revolutionary healthcare disinfectant. This game-changing solution disinfects medical devices in just five minutes, ensuring that even the most resilient microorganisms, which can withstand harsh conditions, are destroyed.* NUGEN® HLD-CD is designed to meet the rigorous demands of healthcare environments. Its broad efficacy spectrum and short contact times make it suitable for all critical areas, including operating rooms, isolation areas, and intensive care units where speed and safety are essential. "We are excited to introduce NUGEN® HLD-CD to the healthcare market," said Uwe Holland, Head of Professional Hygiene EMEA at Arxada. "This solution is a game-changer in disinfection technology for healthcare facilities, providing professionals with a powerful means to improve patie
TCL Introduces the TCL T6C-UK Fire TV Series with QLED 4K, HDR PRO, and Freely23.4.2025 07:30:00 CEST | Press release
LONDON, UNITED KINGDOM / ACCESS Newswire / April 23, 2025 / TCL, the leading consumer electronics brand and the world's second-largest TV brand as well as an official sponsor of the Olympic Games, is proud to announce the launch of its highly anticipated T6C-UK TV series. The new range offers screen sizes from 43" to 85", ensuring there is a perfect option for every home. Featuring QLED technology, 4K resolution, and an intuitive Fire TV experience, the T6C-UK series offers exceptional picture quality, seamless content access, and smart functionality. The TCL T6C-UK series comes Freely-enabled, offering a seamless way to enjoy live and on-demand TV - all in one place and completely free. With Freely built-in, users can access their favourite streaming apps at the click of a button, eliminating the need to switch between platforms. From major channels to must-watch shows, everything is easily accessible from a single, intuitive home screen. Powered by Fire TV, the T6C-UK series also fea
BioNxt Solutions Prepares for Human Bioequivalence Study For MS23.4.2025 03:05:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its human bioequivalence study for its lead Multiple Sclerosis (MS) treatment. BioNxt's lead product, BNT23001, is a proprietary sublingual thin-film formulation of Cladribine for the treatment of MS. Preclinical studies, as reported in internal research data and third-party evaluations, have demonstrated high absorption rates and bioequivalence compared to existing oral tablet therapies. The Company has purchased Cladribine active pharmaceutical ingredient which is necessary to complete the technology transfer process with Gen-Plus, its European Contract Research and Development Organization (CRDO), in Munich, Germany. Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish. T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom